Aadi Starts Small With Fyarro, But Has Tumor-Agnostic Strategy In Mind

 
• By Alaric DeArment
Digital illustration of Cancer cell in colour background
Aadi won FDA approval for Fyarro in PEComa, a rare form of sarcoma • Source: Shutterstock

More from New Products

More from Scrip